insights_auto
Why is ZTS up 2.45%?
Dive Deeperchevron_right
ZTS:NYSE
Zoetis Inc
$71.41
arrow_upward
+2.45%(+1.71) 1D
$71.41
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$69.41
High
$71.47
Low
$69.00
Mkt. cap
29.51B
Avg. vol.
4.59M
Volume
487.00
Dividend
2.97%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.75
52-wk high
$148.30
52-wk low
$68.77
EPS
$6.08
Beta
0.74
Shares outstanding
413.22M
No. of employees
14K
Open
$69.41
High
$71.47
Low
$69.00
Mkt. cap
29.51B
Avg. vol.
4.59M
Volume
487.00
Dividend
2.97%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.75
52-wk high
$148.30
52-wk low
$68.77
EPS
$6.08
Beta
0.74
Shares outstanding
413.22M
No. of employees
14K
News stories
From web sources and news partners
AD HOC NEWS
·
7 hours ago
MarketBeat cites Hold consensus for Zoetis stock
News Corp
·
12 hours ago
Zoetis Inc. stock outperforms competitors on strong trading day
AD HOC NEWS
·
13 hours ago
Zoetis hits a new 52-week low as Zoetis stock gains 2.86 percent
Stock Traders Daily
·
1 day ago
Behavioral Patterns of ZTS and Institutional Flows
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com